SCHEMBL26645173

SCHEMBL26645173

CC(C)(C)OC(=O)N1CCn2nc(Nc3ccc(C(F)(F)F)cc3)cc2C1.[Ar]

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.52
▸ GPR119 Q8TDV5 3/20 0.43
▸ NR1H2 P55055 1/20 0.42
▸ JAK2 O60674 4/20 0.41
▸ JAK1 P23458 1/20 0.41
▸ TGFBR1 P36897 1/20 0.41
▸ JAK3 P52333 3/20 0.41
▸ PTK2 Q05397 3/20 0.41
▸ STS P08842 1/20 0.40
▸ NR3C1 P04150 1/20 0.40
▸ P2RY14 Q15391 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TRPV1 Q8NER1 1/20 0.39
▸ PTPN2 P17706 1/20 0.38
▸ PTPN1 P18031 1/20 0.38
▸ PTPN6 P29350 1/20 0.38
▸ ENPP2 Q13822 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26645416 0.99 MAPT (0.53) MAPTGPR119NR1H2JAK2JAK1
SCHEMBL26645720 0.89 NR1H2 (0.44) MAPTNR1H2JAK2JAK1JAK3
SCHEMBL26645516 0.86 NR1H2 (0.46) GPR119NR1H2JAK2JAK1JAK3
SCHEMBL26645091 0.83 GALR2 (0.53) MAPTNR1H2JAK2JAK1JAK3
SCHEMBL30623068 0.83 GALR2 (0.53) MAPTNR1H2JAK2JAK1JAK3
SCHEMBL26645437 0.82 GALR2 (0.54) MAPTNR1H2JAK2JAK1JAK3
SCHEMBL30622856 0.82 GALR2 (0.54) MAPTNR1H2JAK2JAK1JAK3
SCHEMBL26645099 0.81 GRM5 (0.48) MAPTGPR119NR1H2STSP2RY14
SCHEMBL26645738 0.78 MAPT (0.50) MAPTGPR119JAK2JAK1TGFBR1
SCHEMBL26645565 0.78 MKNK1 (0.54) GPR119NR1H2STSMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 — — EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback